Viewing Study NCT00000969


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-01-01 @ 10:09 PM
Study NCT ID: NCT00000969
Status: COMPLETED
Last Update Posted: 2021-11-04
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: CPCRA 002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View